When it comes to decision making regarding therapeutics for patients with multiple sclerosis (MS), the trend among neurologists has been to utilize a more personalized approach which incorporates the patient into the process. Referred to as shared decision making, this allows for physicians to take into account a number of influencing factors—aside from the effectiveness of the therapy—that may impact which of the growing number of disease-modifying therapies would be best for a given patient.
Carrie Hersh, DO, MSc, an MS neurologist at Cleveland Clinic’s Lou Ruvo Center for Brain Health, spoke with NeurologyLive at the 2019 Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC), May 28-June 1, in Seattle, Washington, about this process. Additionally, she shared her insight into the specific facets that should be taken into account when making these decisions, such as tolerability, affordability, and patient-related factors, such as the desire to start family planning.
Hersh also discussed how to best go about comparing and contrasting disease-modifying therapies, and which measurements and outcomes will be the best to utilize in clinical trials going forward and when collecting real-world data on the effectiveness of these therapies.
- Carrie Hersh, DO, MSc: Shared Decision Making in Multiple Sclerosis ( Download)
- Carrie Hersh, DO, MSc: Addressing Progressive Disease in MS ( Download)
- Carrie Hersh, DO, MSc: Assessing Real-World MS Data to Compare DMTs ( Download)
- A Current overview of MS - Plus Shared Decision Making - Presented by Christopher LaGanke, MD ( Download)
- Engaging the Patient in Treatment Choices ( Download)
- Addressing symptom management in MS ( Download)
- Understanding MS Progression: The Importance of Treatment Adherence ( Download)
- What You Need to Know About COVID-19 and MS - Program 3 ( Download)
- Unlocking the Keys to Health and Wellness in MS ( Download)
- Your Whole Health, Your Whole Team: Decision-Making and Multiple Sclerosis ( Download)
- Health and Wellness while living with MS - an MS Conversations Now, event ( Download)
- Natalizumab improves mental and social health in a real-world MS cohort ( Download)
- What You Need to Know About COVID-19 and MS - Program 5 ( Download)
- Understanding Progression in MS ( Download)
- What You Need to Know About COVID-19 and MS - Program 8 ( Download)
